期刊文献+

血管内皮生长因子基因治疗兔下肢缺血的实验研究 被引量:5

Gene therapy of vascular endothelial growth factor in treatment of hindlimb ischemia in a rabbit model
暂未订购
导出
摘要 目的 :了解血管内皮生长因子 (VEGF)基因治疗兔下肢缺血模型后新生血管和侧支循环形成状况。 方法 :构建h VEGF1 6 5 的真核表达载体 ,通过直接肌肉注射将 h VEGF1 6 5 基因转染缺血部位肌细胞 ,经颈总动脉插管行下肢血管造影。结果 :VEGF治疗组在质粒转染后 2和 4周动脉血管造影显示 ,新生血管数目和侧枝血管形成较对照组明显增加。 结论 :肌细胞能够吸收裸露的 VEGF c DNA质粒并获得局部高效表达 。 Objective:To study the angiogenesis and collateral circulation formation in a rabbit model of hindlimb ischemia after gene therapy of VEGF. Methods:The hVEGF 165 cDNA was cloned into eukaryotic expression vector pcDNA 3. The pcDNA 3/hVEGF 165 was administered intramuscularly, and angiography was performed through the common carotid artery. Results:The angiography was performed 2 and 4 weeks after the initiation of therapy. In VEGF treated animals, neovessels and collateral artery development were more evident compared with controls. Conclusion:Naked DNA of VEGF can be absorbed by muscle cells, and expressed efficiently and locally, to stimulate angiogenesis and collateral circulation in vivo .
出处 《第二军医大学学报》 CAS CSCD 北大核心 2000年第5期447-449,共3页 Academic Journal of Second Military Medical University
基金 国家自然科学基金资助项目!(39780025)
关键词 侧支循环 血管内皮生长因子 基因治疗 下肢缺血 collateral circulation vascular endothelial growth factor gene therapy hindlimb ischemia
  • 相关文献

参考文献4

二级参考文献2

  • 1Takeshita S,Circulation,1994年,90卷,pt2期,II页
  • 2Leung D W,Science,1989年,246卷,4935期,1306页

共引文献4

同被引文献43

  • 1赵明,王会信,周廷冲.重组人骨形态发生蛋白-2成熟肽在大肠杆菌中的表达及其诱导成骨活性[J].生物化学杂志,1994,10(3):319-324. 被引量:79
  • 2Takeshita S, Zheng LP, Brogi E, et al. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest, 1994,93:662-670.
  • 3Poltorak Z, Cohen T, Sivan R, et al. VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix. J Biol Chem, 1997,272:7151-7158.
  • 4Bouloumie A, Schini Kerth VB, Busse R. Vascular endothelial growth factor up regulates nitric oxide synthase expression in endothelial cells. Cardiovasc Res, 1999, 41:773-780.
  • 5Olofsson B, Pajusola K, Kaipainen A, et al. Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci USA, 1996,93:2576-2581.
  • 6Cao Y, Chen H, Zhou L, et al. Heterodimers of placenta growth factor/vascular endothelial growth factor: Endothelial activity, tumor cell expression, and high affinity binding to Flk 1/KDR. J Biol Chem, 1996,271:3154-3162.
  • 7Padubidri A, Browne E Jr, Effect of vascular endothelial growth factor(VEGF) on survival of random extension of axial pattern skin flaps in the rat. Ann Plast Surg, 1996,37:604-611.
  • 8Kryger Z, Dogan T, Zhang F, et al. Effects of VEGF administration following ischemic on survival of the gracilis muscle flap in the rat. Ann Plast Surg, 1999,43:172-178.
  • 9Kryger Z, Zhang F, Dogan T, et al. The effects of VEGF on survival of a random flap in the rat: examination of various routes of administration. Br J Plast Surg, 2000,53:234-239.
  • 10Carroll CM Carroll SM, Schuschke DA, et al. Augmentation of skeletal muscle flap survival using platelet derived growth factor. Plast Reconstr Surg, 1998,102:407-415.

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部